Intervention Review

Risperidone versus placebo for schizophrenia

  1. Ranganath D Rattehalli1,*,
  2. Mahesh B Jayaram2,
  3. Michael Smith3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 4 FEB 2008

DOI: 10.1002/14651858.CD006918.pub2

How to Cite

Rattehalli RD, Jayaram MB, Smith M. Risperidone versus placebo for schizophrenia. Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No.: CD006918. DOI: 10.1002/14651858.CD006918.pub2.

Author Information

  1. 1

    Millfield House, Leeds, UK

  2. 2

    Leeds Partnership Foundation NHS Trust, CMHT, Leeds, UK

  3. 3

    Leeds Partnership Foundation Trust, Child and Adolescent Psychiatry, Leeds, UK

*Ranganath D Rattehalli, Millfield House, Kirk Lane, Leeds, LS19 7LX, UK.

Publication History

  1. Publication Status: New
  2. Published Online: 20 JAN 2010


Options for accessing this content:

  • If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
  • Login via other institutional login options
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

Login via OpenAthens


Search for your institution's name below to login via Shibboleth.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

Patient Access

Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.